Pf
Non verificato

Pfizer Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute
01/12/2025
Web e Social Network
Telefonia e Varie
Finanza
Biotecnologia
Farmaceutica
Salute
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
1.00
21/11/2025
Multimedialità
Mercato del lavoro
Eventi
Industria
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
1.00
13/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Mercato azionario
Pfizer Completes Acquisition of Metsera
1.00
12/11/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Web e Social Network
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
1.00
05/11/2025
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Legge/Diritto
Pfizer Responds to Delaware Chancery Court Ruling
1.00
04/11/2025
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Telefonia e Varie
Mercato azionario
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
1.00
03/11/2025
Associazioni/Professionisti
Salute
Legge/Diritto
Farmaceutica
Biotecnologia
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
1.00
31/10/2025
Mercato azionario
Legge/Diritto
Salute
Farmaceutica
Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement
1.00
31/10/2025
Biotecnologia
Farmaceutica
Salute
Mercato azionario
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition
1.00
30/10/2025
Biotecnologia
Farmaceutica
Salute
Pfizer Addresses Proposal for Metsera
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0